Evidence map›Paper›PMID 34500777›Full record

ArticleMolecules (Basel, Switzerland)2021

Discrimination of Methionine Sulfoxide and Sulfone by Human Neutrophil Elastase.

Darren Leahy, Cameron Grant, Alex Jackson, Alex Duff, Nicholas Tardiota, Jessica Van Haeften, Xingchen Chen, Jonathan M Peake, Michael D Kruppa, Eliot T Smith and 3 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 62% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Darren LeahySchool of Biomedical Science, Faculty of Health, Queensland University of Technology, Brisbane, QLD 4059, Australia.
Cameron GrantSchool of Biomedical Science, Faculty of Health, Queensland University of Technology, Brisbane, QLD 4059, Australia.
Alex JacksonSchool of Biomedical Science, Faculty of Health, Queensland University of Technology, Brisbane, QLD 4059, Australia.
Alex DuffSchool of Biomedical Science, Faculty of Health, Queensland University of Technology, Brisbane, QLD 4059, Australia.
Nicholas TardiotaSchool of Biomedical Science, Faculty of Health, Queensland University of Technology, Brisbane, QLD 4059, Australia.ORCID 0000-0002-4594-473X
Jessica Van HaeftenSchool of Biomedical Science, Faculty of Health, Queensland University of Technology, Brisbane, QLD 4059, Australia.
Xingchen ChenCentre for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China.
Jonathan M PeakeSchool of Biomedical Science, Faculty of Health, Queensland University of Technology, Brisbane, QLD 4059, Australia.
Michael D KruppaDepartment of Biomedical Sciences, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, USA.
Eliot T SmithDepartment of Otolaryngology Head and Neck Surgery, Stanford School of Medicine, Stanford University, Stanford, CA 94305-5739, USA.
David A JohnsonDepartment of Biomedical Sciences, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, USA.
William B LottSchool of Biomedical Science, Faculty of Health, Queensland University of Technology, Brisbane, QLD 4059, Australia.
Jonathan M HarrisSchool of Biomedical Science, Faculty of Health, Queensland University of Technology, Brisbane, QLD 4059, Australia.
Queensland University of Technology · AUEast Tennessee State University · USChinese Academy of Sciences · CNStanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human neutrophil elastase (HNE) is a uniquely destructive serine protease with the ability to unleash a wave of proteolytic activity by destroying the inhibitors of other proteases. Although this phenomenon forms an important part of the innate immune response to invading pathogens, it is responsible for the collateral host tissue damage observed in chronic conditions such as chronic obstructive pulmonary disease (COPD), and in more acute disorders such as the lung injuries associated with COVID-19 infection. Previously, a combinatorially selected activity-based probe revealed an unexpected substrate preference for oxidised methionine, which suggests a link to oxidative pathogen clearance by neutrophils. Here we use oxidised model substrates and inhibitors to confirm this observation and to show that neutrophil elastase is specifically selective for the di-oxygenated methionine sulfone rather than the mono-oxygenated methionine sulfoxide. We also posit a critical role for ordered solvent in the mechanism of HNE discrimination between the two oxidised forms methionine residue. Preference for the sulfone form of oxidised methionine is especially significant. While both host and pathogens have the ability to reduce methionine sulfoxide back to methionine, a biological pathway to reduce methionine sulfone is not known. Taken together, these data suggest that the oxidative activity of neutrophils may create rapidly cleaved elastase "super substrates" that directly damage tissue, while initiating a cycle of neutrophil oxidation that increases elastase tissue damage and further neutrophil recruitment.

Indexed as

Immunity, InnateBiocatalysisCatalytic DomainCOVID-19Enzyme AssaysHost-Pathogen InteractionsHumansLeukocyte ElastaseLungMethionineMolecular Dynamics SimulationNeutrophil InfiltrationNeutrophilsOxidation-ReductionProteolysisPulmonary Disease, Chronic ObstructiveELANE protein, humanLeukocyte ElastaseMethioninemethionine sulfonemethionine sulfoxidehuman neutrophil elastasemethionine oxidationmethionine sulfonepeptide aldehydesubstrate guided inhibitor designsubstrate selectivity

Identifiers

PMID34500777
PMCPMC8434204
OpenAlexW3196450431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.